Related references
Note: Only part of the references are listed.Five-Year Impact of Different Multi-Year Mass Drug Administration Strategies on Childhood Schistosoma mansoni-Associated Morbidity: A Combined Analysis from the Schistosomiasis Consortium for Operational Research and Evaluation Cohort Studies in the Lake Victoria Regions of Kenya and Tanzania
Ye Shen et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2019)
Schistosoma mansoni Mass Drug Administration Regimens and Their Effect on Morbidity among Schoolchildren over a 5-Year Period-Kenya, 2010-2015
Anita D. Sircar et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2018)
Human schistosomiasis in the post mass drug administration era
Francisca Mutapi et al.
LANCET INFECTIOUS DISEASES (2017)
Schistosoma mansoni-Associated Morbidity among Preschool-Aged Children along the Shores of Lake Victoria in Uganda
Allen Nalugwa et al.
TROPICAL MEDICINE AND INFECTIOUS DISEASE (2017)
Schistosoma mansoni-Related Hepatosplenic Morbidity in Adult Population on Kome Island, Sengerema District, Tanzania
Godfrey M. Kaatano et al.
KOREAN JOURNAL OF PARASITOLOGY (2015)
High Schistosoma mansoni Disease Burden in a Rural District of Western Zambia
Mable M. Mutengo et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2014)
Clinico-epidemiological study of Schistosomiasis mansoni in Waja-Timuga, District of Alamata, northern Ethiopia
Nigus Abebe et al.
PARASITES & VECTORS (2014)
The WHO ultrasonography protocol for assessing hepatic morbidity due to Schistosoma mansoni. Acceptance and evolution over 12 years
Tarik el Scheich et al.
PARASITOLOGY RESEARCH (2014)
Treatment and education reduce the severity of schistosomiasis periportal fibrosis
Paula Carolina Valenca Silva et al.
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL (2013)
Hepatosplenic morbidity due to Schistosoma mansoni in schoolchildren on Ukerewe Island, Tanzania
Tarik El Scheich et al.
PARASITOLOGY RESEARCH (2012)
Reversibility of schistosomal periportal thickening/fibrosis after praziquantel therapy: A twenty-six month follow-up study in Ethiopia
Nega Berhe et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2008)
The unacknowledged impact of chronic schistosomiasis
Charles H. King et al.
CHRONIC ILLNESS (2008)
Detailed clinical and ultrasound examination of children and adolescents in a Schistosoma mansoni endemic area in Kenya:: hepatosplenic disease in the absence of portal fibrosis
BJ Vennervald et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2004)
Hepatosplenic morbidity in two neighbouring communities in Uganda with high levels of Schistosoma mansoni infection but very different durations of residence
M Booth et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2004)
Measuring morbidity in schistosomiasis mansoni: relationship between image pattern, portal vein diameter and portal branch thickness in large-scale surveys using new WHO coding guidelines for ultrasound in schistosomiasis
CH King et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2003)
Geographic differences in hepatosplenic complications of schistosomiasis mansoni and explanatory factors of morbidity
P Boisier et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2001)